News Headlines

  1. Global Survey Finds CROs Undergoing Major Changes To Speed Clinical Trials 10/29/2019

    Contract research organizations (CROs) are making significant progress in advancing the industrywide move to improve clinical trial performance, according to the Veeva 2019 Unified Clinical Operations Survey: Annual CRO Report, one of the largest-ever surveys of clinical operations professionals globally.

  2. Cesca Therapeutics Forms Joint Venture With HealthBanks Biotech (USA) To Provide Immune Cell Banking And Cell Processing Services 10/22/2019

    Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company has entered into a definitive joint venture agreement with HealthBanks Biotech (USA) Inc., one of the world's leading stem cell bank networks, to commercialize its proprietary cell processing platform, CAR-TXpress™, for use in immune cell banking as well as for cell-based contract development and manufacturing services (CMO/CDMO).

  3. Halloran Consulting Group Launches Speaker Series To Drive Meaningful Discussions And Share Insights On Medical Advancements In The Life Science Industry 10/21/2019

    Halloran Consulting Group, a life science regulatory, quality and clinical consulting firm, recently announced the launch of its Speaker Series, an interactive speaking circuit featuring Halloran’s most experienced strategic thinkers.

  4. CTTI Releases New Recommendations And Resources For Using Real-World Data To Plan Trial Eligibility Criteria And Recruit Participants 10/17/2019

    During a public webinar recently, the Clinical Trials Transformation Initiative (CTTI) will release new recommendations and resources on how to use real-world data (RWD) to evaluate trial eligibility criteria and recruit potential research participants.

  5. Spring Bank Announces Interim Top-Line Results From The First Cohort Of The Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy In Chronic Hepatitis B Patients 10/17/2019

    Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, recently announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences’ Vemlidy (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection.

  6. Benefits To UK’s NHS Of Delivering Commercial Contract Research Valued At £383.6M 10/16/2019

    The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network’s (NIHR CRN) activities to support clinical research in England.

  7. Enterprise Therapeutics Awarded Up To £5.7M ($7M) From Cystic Fibrosis Foundation 10/15/2019

    Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, recently announced it has been awarded up to £5.7M ($7M) funding under the Therapeutics Development Award programme from the Cystic Fibrosis Foundation.

  8. Mogrify Raises Additional $16M To Advance Its Mission To Transform The Development Of Life-Saving Cell Therapies 10/14/2019

    Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, recently announced the initial close of its Series A funding. The Company raised $16M USD in this round, bringing the total investment to over $20M USD to date.

  9. Syneos Health Wins Society For Clinical Research Sites Eagle Award For Third Consecutive Year 10/14/2019

    Syneos Health, the only fully integrated biopharmaceutical solutions organization, recently announced that the Company was awarded the Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category for a third consecutive year.

  10. Sharp Clinical Officially Opens £9.5M Facility In Rhymney 10/10/2019

    Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, officially opened its new £9.5M facility in Rhymney at an Open House and ribbon-cutting ceremony recently.